CA1062704A - 9-(3-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, 9-(2,3-DI-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, AND METHOD FOR THEIR PRODUCTION - Google Patents
9-(3-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, 9-(2,3-DI-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, AND METHOD FOR THEIR PRODUCTIONInfo
- Publication number
- CA1062704A CA1062704A CA278,496A CA278496A CA1062704A CA 1062704 A CA1062704 A CA 1062704A CA 278496 A CA278496 A CA 278496A CA 1062704 A CA1062704 A CA 1062704A
- Authority
- CA
- Canada
- Prior art keywords
- arabinofuranosyl
- adenine
- beta
- compounds
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical class NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 229960000643 adenine Drugs 0.000 claims description 45
- 229930024421 Adenine Natural products 0.000 claims description 44
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 14
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims description 8
- -1 isobutyryl group Chemical group 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000005210 alkyl ammonium group Chemical group 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 abstract description 20
- 239000003443 antiviral agent Substances 0.000 abstract description 5
- 125000005207 tetraalkylammonium group Chemical group 0.000 abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 16
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 11
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical group [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 125000003317 D-arabinofuranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 241001529453 unidentified herpesvirus Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 125000000328 arabinofuranosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000013553 cell monolayer Substances 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- MQFLXLMNOHHPTC-UHFFFAOYSA-N 1-isothiocyanato-9-(methylsulfinyl)nonane Chemical class CS(=O)CCCCCCCCCN=C=S MQFLXLMNOHHPTC-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- UCTLHLZWKJIXJI-LXIBVNSESA-N [(3s,8r,9s,10r,13s,14s)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(Cl)=C(C=O)C[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 UCTLHLZWKJIXJI-LXIBVNSESA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- KCWYOFZQRFCIIE-UHFFFAOYSA-N ethylsilane Chemical compound CC[SiH3] KCWYOFZQRFCIIE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- LSACYLWPPQLVSM-UHFFFAOYSA-N isobutyric acid anhydride Chemical compound CC(C)C(=O)OC(=O)C(C)C LSACYLWPPQLVSM-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960001407 sodium bicarbonate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/687,273 US4055717A (en) | 1976-05-17 | 1976-05-17 | 9-(3-O-Acyl-β-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-β-D-arabinofuranosyl)-adenine compounds, and method for their production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1062704A true CA1062704A (en) | 1979-09-18 |
Family
ID=24759770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA278,496A Expired CA1062704A (en) | 1976-05-17 | 1977-05-16 | 9-(3-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, 9-(2,3-DI-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, AND METHOD FOR THEIR PRODUCTION |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4055717A (show.php) |
| JP (1) | JPS535197A (show.php) |
| CA (1) | CA1062704A (show.php) |
| DE (1) | DE2722095A1 (show.php) |
| FR (1) | FR2351993A1 (show.php) |
| GB (1) | GB1538008A (show.php) |
| NL (1) | NL7705404A (show.php) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU542271B2 (en) * | 1980-06-23 | 1985-02-14 | Regents Of The University Of Minnesota | Adenine nucleosides |
| US4338310A (en) * | 1981-01-16 | 1982-07-06 | The Regents Of The University Of Minnesota | Alkoxyalkanoate esters of arabinofuranosyladenine |
| US4315000A (en) * | 1980-07-07 | 1982-02-09 | Warner-Lambert Company | β-D-Arabinofuranosylimidazo(4,5-c)pyridine compounds and methods for their production |
| US4334059A (en) * | 1980-10-20 | 1982-06-08 | Bio Logicals Inc. | Silylated arabino-base compounds |
| US4352795A (en) * | 1981-01-29 | 1982-10-05 | Warner-Lambert Company | 7-β-D-Arabinofuranosyl-7H-pyrrolo[2,3-d]pyrimidine compounds and methods for their production |
| US4499084A (en) * | 1983-02-03 | 1985-02-12 | Dixon Glen J | Ara-A Antiviral composition and method of administering the same |
| US4814339A (en) * | 1986-02-11 | 1989-03-21 | Advanced Biologics, Inc. | Treatment for Alzheimer's disease |
| US4942165A (en) * | 1986-02-11 | 1990-07-17 | Advanced Biologics, Inc. | Treatment for Alzheimer's disease |
| GB8712745D0 (en) * | 1987-05-30 | 1987-07-01 | Wellcome Found | Antiviral compounds |
| US20070167353A1 (en) * | 2003-10-24 | 2007-07-19 | John Hilfinger | Prodrug composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3457253A (en) * | 1965-06-01 | 1969-07-22 | Upjohn Co | 5',5'-di-(ara)-nucleoside phosphates |
| US3354160A (en) * | 1965-07-22 | 1967-11-21 | Hoffmann La Roche | Tri-lower alkyl-silyl-5-fluoropyrimidines |
| US3309358A (en) * | 1965-09-20 | 1967-03-14 | Upjohn Co | 7-deazaadenine 2', 5'-and 3', 5'-dinucleoside phosphate and process therefor |
| US3651045A (en) * | 1968-10-21 | 1972-03-21 | Parke Davis & Co | 9-(beta-d-arabinofuranosyl)adenine esters and methods for their production |
-
1976
- 1976-05-17 US US05/687,273 patent/US4055717A/en not_active Expired - Lifetime
-
1977
- 1977-05-16 NL NL7705404A patent/NL7705404A/xx not_active Application Discontinuation
- 1977-05-16 JP JP5626477A patent/JPS535197A/ja active Pending
- 1977-05-16 CA CA278,496A patent/CA1062704A/en not_active Expired
- 1977-05-16 GB GB20568/77A patent/GB1538008A/en not_active Expired
- 1977-05-16 FR FR7714901A patent/FR2351993A1/fr active Granted
- 1977-05-16 DE DE19772722095 patent/DE2722095A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| FR2351993A1 (fr) | 1977-12-16 |
| FR2351993B1 (show.php) | 1981-01-09 |
| JPS535197A (en) | 1978-01-18 |
| NL7705404A (nl) | 1977-11-21 |
| DE2722095A1 (de) | 1977-12-08 |
| US4055717A (en) | 1977-10-25 |
| GB1538008A (en) | 1979-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2014662C (en) | Anti-virals | |
| CA1062704A (en) | 9-(3-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, 9-(2,3-DI-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, AND METHOD FOR THEIR PRODUCTION | |
| CA2126601A1 (en) | Phosphonate-nucleotide ester derivatives | |
| US4048432A (en) | 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production | |
| US4055718A (en) | 9-(2-O-Acyl-β-D-arabinofuranosyl)-adenine compounds and method for their production | |
| HK1005739B (en) | Griseolic acid derivatives, their preparation and their use | |
| HK1005739A1 (en) | Griseolic acid derivatives, their preparation and their use | |
| KR19990087275A (ko) | 트리테르펜 유도체 및 간질환 치료제 | |
| AU596800B2 (en) | Improvements in or relating to organic compounds | |
| US5097023A (en) | α-glucosidase inhibitors | |
| EP0227844B1 (en) | Antiviral drug | |
| US5371077A (en) | Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them | |
| CA1067072A (en) | 9-(5-O-ACYL-.beta.-D-ARABINOFURANOSYL)ADENINE COMPOUNDS AND METHOD FOR THEIR PRODUCTION | |
| FI89494B (fi) | Foerfarande foer framstaellning av nya sackaridderivat | |
| CA1252058A (en) | Enzyme-inhibitory griseolic acid derivatives, and their use | |
| EP0491793B1 (en) | 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents | |
| EP0049110A1 (en) | Antiviral agents, their preparation and use | |
| WO1987005606A1 (fr) | TRIMYCOLATE DE alpha, alpha-TREHALOSE ET COMPOSITION MEDICINALE | |
| JPH01246297A (ja) | ベータ―２’，２’―ジフルオロヌクレオシド類の製造方法 | |
| EP0450102A1 (en) | Nucleoside derivative | |
| EP0180608B1 (en) | 2,3-diamino-2,3-didesoxyhexose derivatives, processes for their preparation and their use | |
| US4212941A (en) | Method for the production of 9-(2-O-acyl-β-D-arabinofuranosyl)adenine compounds | |
| US4992427A (en) | 2-substituted inosines and their use as antiviral agents | |
| US4104461A (en) | 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine | |
| HU193238B (en) | Process for preparing indanyl-derivatives and pharmaceutical compositions containing such compounds |